Springer Announces Deal to Purchase Marketing and Publishing Services from Wolters Kluwer
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
According to Nancy McKinstry, CEO and Chairman of the Executive Board of Wolters Kluwer, "The sale of our pharma-related business is part of our strategy to focus on our core health markets and accelerate growth by providing innovative solutions to clinicians globally."
According to a statement by Wolters Kluwer, "proceeds from this divestment are expected to be used for general corporate purposes including the reduction of debt levels in line with the company's stated objectives and investments in the business."
0 Comments
View Comments
Related Content
Comments